001     144880
005     20240229112641.0
024 7 _ |a 10.1002/ijc.32165
|2 doi
024 7 _ |a pmid:30694528
|2 pmid
024 7 _ |a 0020-7136
|2 ISSN
024 7 _ |a 1097-0215
|2 ISSN
024 7 _ |a altmetric:54697890
|2 altmetric
037 _ _ |a DKFZ-2019-02304
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Vrieling, Alina
|0 0000-0002-8178-2125
|b 0
245 _ _ |a One-carbon metabolism biomarkers and risk of urothelial cell carcinoma in the European prospective investigation into cancer and nutrition.
260 _ _ |a Bognor Regis
|c 2019
|b Wiley-Liss
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1569323773_24968
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Published associations between dietary folate and bladder cancer risk are inconsistent. Biomarkers may provide more accurate measures of nutrient status. This nested case-control analysis within the European Prospective Investigation into Cancer and Nutrition (EPIC) investigated associations between pre-diagnostic serum folate, homocysteine, vitamins B6 and B12 and the risk of urothelial cell carcinomas of the bladder (UCC). A total of 824 patients with newly diagnosed UCC were matched with 824 cohort members. Serum folate, homocysteine, and vitamins B6 and B12 were measured. Odds ratios (OR) and 95% confidence intervals (CI) for total, aggressive, and non-aggressive UCC were estimated using conditional logistic regression with adjustment for smoking status, smoking duration and intensity, and other potential confounders. Additionally, statistical interaction with smoking status was assessed. A halving in serum folate concentrations was moderately associated with risk of UCC (OR: 1.18; 95% CI: 0.98-1.43), in particular aggressive UCC (OR: 1.34; 95% CI: 1.02-1.75; p-heterogeneity = 0.19). Compared to never smokers in the highest quartile of folate concentrations, this association seemed only apparent among current smokers in the lowest quartile of folate concentrations (OR: 6.26; 95% CI: 3.62-10.81, p-interaction = 0.07). Dietary folate was not associated with aggressive UCC (OR: 1.26; 95% CI: 0.81-1.95; p-heterogeneity = 0.14). No association was observed between serum homocysteine, vitamins B6 and B12 and risk of UCC. This study suggests that lower serum folate concentrations are associated with increased UCC risk, in particular aggressive UCC. Residual confounding by smoking cannot be ruled out and these findings require confirmation in future studies with multiple measurements.
536 _ _ |a 313 - Cancer risk factors and prevention (POF3-313)
|0 G:(DE-HGF)POF3-313
|c POF3-313
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Bueno-De-Mesquita, H Bas
|b 1
700 1 _ |a Ros, Martine M
|b 2
700 1 _ |a Kampman, Ellen
|b 3
700 1 _ |a Aben, Katja K
|b 4
700 1 _ |a Büchner, Frederike L
|b 5
700 1 _ |a Jansen, Eugène H
|b 6
700 1 _ |a Roswall, Nina
|0 0000-0003-3071-1658
|b 7
700 1 _ |a Tjønneland, Anne
|b 8
700 1 _ |a Boutron-Ruault, Marie-Christine
|0 0000-0002-5956-5693
|b 9
700 1 _ |a Cadeau, Claire
|b 10
700 1 _ |a Chang-Claude, Jenny
|0 P:(DE-He78)c259d6cc99edf5c7bc7ce22c7f87c253
|b 11
|u dkfz
700 1 _ |a Kaaks, Rudolf
|0 P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a
|b 12
|u dkfz
700 1 _ |a Weikert, Steffen
|b 13
700 1 _ |a Boeing, Heiner
|b 14
700 1 _ |a Trichopoulou, Antonia
|b 15
700 1 _ |a Lagiou, Pagona
|b 16
700 1 _ |a Trichopoulos, Dimitrios
|b 17
700 1 _ |a Sieri, Sabina
|b 18
700 1 _ |a Palli, Domenico
|0 0000-0002-5558-2437
|b 19
700 1 _ |a Panico, Salvatore
|b 20
700 1 _ |a Peeters, Petra H
|b 21
700 1 _ |a Weiderpass, Elisabete
|b 22
700 1 _ |a Skeie, Guri
|b 23
700 1 _ |a Jakszyn, Paula
|b 24
700 1 _ |a Chirlaque, María-Dolores
|b 25
700 1 _ |a Ardanaz, Eva
|b 26
700 1 _ |a Sánchez, María-José
|b 27
700 1 _ |a Ehrnström, Roy
|b 28
700 1 _ |a Malm, Johan
|b 29
700 1 _ |a Ljungberg, Börje
|b 30
700 1 _ |a Khaw, Kay-Tee
|b 31
700 1 _ |a Wareham, Nick J
|b 32
700 1 _ |a Brennan, Paul
|b 33
700 1 _ |a Johansson, Mattias
|b 34
700 1 _ |a Riboli, Elio
|b 35
700 1 _ |a Kiemeney, Lambertus A
|b 36
773 _ _ |a 10.1002/ijc.32165
|g Vol. 145, no. 9, p. 2349 - 2359
|0 PERI:(DE-600)1474822-8
|n 9
|p 2349 - 2359
|t International journal of cancer
|v 145
|y 2019
|x 1097-0215
909 C O |o oai:inrepo02.dkfz.de:144880
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 11
|6 P:(DE-He78)c259d6cc99edf5c7bc7ce22c7f87c253
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 12
|6 P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-313
|2 G:(DE-HGF)POF3-300
|v Cancer risk factors and prevention
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2019
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b INT J CANCER : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b INT J CANCER : 2017
920 1 _ |0 I:(DE-He78)C020-20160331
|k C020
|l Epidemiologie von Krebserkrankungen
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C020-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21